Targeted immune checkpoints are the programmed cell death 1 (PD-1) and the cytotoxic T lymphocyte antigen 4 (CTLA-4), both expressed on T cells, while PD-L1 is produced by tumor cells [65]. The gene discussed is PDCD1; the disease is neoplasm.